Specifically with regard to the current markers for EGFR inhibition therapy and known (metastatic) colorectal cancer risk factor genes KRAS, NRAS, and BRAF, no association with growth patterns was found [34–36]. The gene discussed is KRAS; the disease is colorectal cancer.